This fourth webinar in the “Let’s Talk MPTs” learning series will provide MPT product developers and other stakeholders an overview of clinical development and regulatory considerations when developing products that combine one or more active pharmaceutical ingredients (APIs) into an MPT product.
발표자
• Deven Shah – Chemistry, Manufacturing, & Control (CM&C) Lead at Certara
• Kevin Hershberger – Vice President of Integrated Drug Development at Certara
• Tamra Goodrow – Regulatory Consultant & Principal at Deer Run Regulatory Consulting
